Invatec Comments On First Clinical Results Of Drug Eluting Balloon Technology For Bel

[PTG Studios]

Invatec, a comprehensive innovator of interventional products, welcomed the first clinical results of the Drug Eluting Balloon (DEB), IN.PACT Amphirion, for complex Critical Limb Ischemia (CLI) in Below the Knee (BtK). As Dr. Andrej Schmidt, leading investigator from the Park Hospital Leipzig, reported during the LINC congress, preliminary results indicate a dramatic reduction in restenosis rate by application of the Drug Eluting Balloon. "In our experience, 69% of Clinical Limb Ischemia patients with long lesions show restenosis after 3 months...</img>
</img>


Read Article from Medical News Today ...